Association between Plasmatic Ceramides Profile and ASTALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of Obesity

Abstract EN

Objective.

To assess the association between plasma ceramides and hepatic steatosis (HS) in adolescents, independently of obesity.

Materials and Methods.

Ninety-four adolescents from two previous studies conducted and published by our crew were included.

Study subjects were stratified in three groups: normal weight (n=18), obesity (n=34), and obesity + HS (n=42).

The presence of HS was defined when ALT/AST ratio was <1.

Ceramides subspecies (C14:0, C16:0, C18:0, C24:0, and C24:1) were determined by LC/MS.

Results.

All ceramides correlated directly with ALT levels and inversely with ALT/AST ratio; the strongest correlation was observed among C14:0 ceramide (r=0.41 and r=-0.54, resp.; P<0.001).

Furthermore, significant correlations were observed between cholesterol and all ceramides except for C24:1 ceramide.

Interestingly ceramides C14:0, C18:0, and C24:1 correlated directly with both fasting insulin and HOMA-IR index.

For assessing HS, a cut-off point of 10.3 nmol/L for C14:0 ceramide reported a sensitivity of 92.7% and a specificity of 73.5% when normal weight and obesity groups (n=52) were compared against obesity + HS group (n=42).

Positive and negative predictive values were 77.5% and 90.2%, respectively.

Conclusions.

Plasma ceramides are closely associated with hepatic steatosis in adolescents.

C14:0 ceramide could be a novel biomarker of HS independently of obesity.